E
ECO Animal Health Group PLC
LSE:EAH
ECO Animal Health Group PLC
LSE:EAH
Price:
98.5
GBX
5.35%
Market Closed
Market Cap:
£66.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
ECO Animal Health Group PLC
LSE:EAH
|
UK |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
US |
Multiples-Based Value
The Multiples-Based Value of one EAH stock under the Base Case scenario is 84.2 GBX. Compared to the current market price of 98.5 GBX, ECO Animal Health Group PLC is Overvalued by 15%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EAH
Multiples-Based Value
84.2
GBX
Overvaluation 15%
E
Multiples Across Competitors
EAH Competitors Multiples
ECO Animal Health Group PLC Competitors
ECO Animal Health Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
E
|
ECO Animal Health Group PLC
LSE:EAH
|
66.7m GBP | 0.8 | 22.1 | 5.5 | 7.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD | 13.4 | 42.2 | 28.5 | 30.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.7 | 7.9 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP | 2.7 | 15.6 | 8.4 | 10.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
